In a peer-reviewed paper published last week, U.K. researchers said they found a link between the Pfizer-BioNTech COVID-19 and vaccine leprosy adverse events in people who previously were diagnosed with the condition.
The Centers for Disease Control and Prevention (CDC) meanwhile issued a case report of leprosy in central Florida this month, citing rising evidence that leprosy has become endemic in the south-eastern United States.
According to the CDC, cases of leprosy more than doubled in Florida over the last decade. In the U.K. study, researchers analyzed patient records of 52 individuals who were diagnosed with leprosy following the Pfizer-BioNTech COVID-19 vaccine.
From 2022 to 2023, the number of new leprosy cases surged to 626, the highest since 2013-14, when 627 cases were reported. Climate change seems to take the fall for this one too.